Japan's Takeda flags profit slide as it bolsters drug pipeline https://ift.tt/Pe3QCfM

Japan's biggest drugmaker spent big in the past year to replenish its pipeline to make up for the loss of exclusivity on big sellers and give it time to develop some 40 treatments in the clinical stage.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/xPSgsjG